Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 117
Filter
1.
Clin Transplant ; 37(8): e15035, 2023 08.
Article in English | MEDLINE | ID: mdl-37265180

ABSTRACT

BACKGROUND: Pediatric liver transplant recipients are at increased risk of post-transplant infections. The purpose of this study was to quantify hepatitis A and B non-immunity based on antibody titers in liver transplant recipients. METHODS: We conducted a retrospective chart review of 107 pediatric liver transplant recipients at a single medical center from 2000 to 2017. We compared hepatitis immune patients to non-immune patients and studied response to vaccination in patients immunized post-transplantation. RESULTS: Eighty-one percent of patients had pre-transplant immunity to hepatitis A whereas 68% had pre-transplant immunity to hepatitis B. Post-transplant hepatitis B immunity decreased to 33% whereas post-transplant hepatitis A immunity remained high at 82%. Older age and time since transplantation were significantly associated with hepatitis B non-immunity. Most patients responded to doses post-transplantation with 78% seroconversion following hepatitis A re-immunization and 83% seroconversion following hepatitis B re-immunization. CONCLUSIONS: Pediatric liver transplant recipients are at risk of hepatitis A and B non-immunity, particularly with respect to hepatitis B. Boosters post-transplant may improve immunity to hepatitis viruses.


Subject(s)
Hepatitis A , Hepatitis B , Liver Transplantation , Humans , Child , Hepatitis A/epidemiology , Hepatitis A/etiology , Liver Transplantation/adverse effects , Prevalence , Retrospective Studies , Hepatitis B/prevention & control , Transplant Recipients , Hepatitis B Vaccines
2.
Transpl Immunol ; 69: 101447, 2021 12.
Article in English | MEDLINE | ID: mdl-34400246

ABSTRACT

BACKGROUND/OBJECTIVES: Rejection and infectious enteritis in intestinal transplant (ITx) patients present with virtually identical symptoms. Currently, the gold standard for differentiating between these two conditions is endoscopy, which is invasive and costly. Our primary aim was to identify differences in peripheral blood cytokines during episodes of acute cellular rejection (ACR) and infectious enteritis in patients with intestinal transplants. METHODS: This was a prospective, cross-sectional study involving ITx patients transplanted between 2000 and 2016. We studied 63 blood samples collected from 29 ITx patients during periods of normal (n = 24) and abnormal (n = 17) allograft function. PBMCs from whole blood samples were cultured under unstimulated or stimulated conditions with phytohemagglutinin (PHA). The supernatant from these cultures were collected to measure cytokine and chemokine levels using a 38-plex luminex panel. RESULTS: Our study found that cytokines and chemokines are differentially expressed in normal, ACR, and infectious enteritis samples under unstimulated conditions based on heatmap analysis. Although each cohort displayed distinctive signatures, only MDC (p = 0.037) was found to be significantly different between ACR and infectious enteritis. Upon stimulation of PBMCs, patients with ACR demonstrated increased immune reactivity compared to infectious enteritis; though this did not reach statistical significance. CONCLUSIONS: To our knowledge, this is the first comprehensive study comparing cytokine expression during acute rejection and infectious enteritis in intestinal transplant recipients. Our results suggest that cytokines have the potential to be used as clinical markers for risk stratification and/or diagnosis of ACR and infectious enteritis.


Subject(s)
Cytokines , Graft Rejection , Chemokines , Cross-Sectional Studies , Graft Rejection/diagnosis , Humans , Prospective Studies
4.
Am J Transplant ; 14(4): 779-87, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24580828

ABSTRACT

The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantibody-mediated adverse consequences are increasingly being recognized. To better define the current state of this topic, we assembled experts to provide insights, explore controversies and develop recommendations for future research on the consequences of DSA in liver transplantation. This article summarizes the proceedings of this inaugural meeting. Several insights emerged. Acute antibody-mediated rejection (AMR), although rarely diagnosed, is increasingly understood to overlap with T cell-mediated rejection. Isolated liver allograft recipients are at increased risk of early allograft immunologic injury when preformed DSA are high titer and persist posttransplantation. Persons who undergo simultaneous liver-kidney transplantation are at risk of renal AMR when Class II DSA persist posttransplantation. Other under-appreciated DSA associations include ductopenia and fibrosis, plasma cell hepatitis, biliary strictures and accelerated fibrosis associated with recurrent liver disease. Standardized DSA testing and diagnostic criteria for both acute and chronic AMR are needed to distil existing associations into etiological processes in order to develop responsive therapeutic strategies.


Subject(s)
Graft Rejection/immunology , HLA Antigens/immunology , Isoantibodies/immunology , Liver Diseases/immunology , Liver Transplantation , Practice Guidelines as Topic , Tissue Donors , Humans , Liver Diseases/surgery , Prognosis , Research Report
5.
Am J Transplant ; 12(6): 1367-9, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22642472
6.
Am J Transplant ; 12(5): 1218-28, 2012 May.
Article in English | MEDLINE | ID: mdl-22300520

ABSTRACT

To identify biomarkers of operational tolerance in pediatric and adult liver transplant recipients, transcriptional profiles were examined from 300 samples by microarrays and Q-PCR measurements of blood specimens from pediatric and adult liver transplant recipients and normal tissues. Tolerance-specific genes were validated in independent samples across two different transplant programs and validated by Q-PCR. A minimal set of 13 unique genes, highly expressed in natural killer cells (p = 0.03), were significantly expressed in both pediatric and adult liver tolerance, irrespective of different clinical and demographic confounders. The performance of this gene set by microarray in independent samples was 100% sensitivity and 83% specificity and the AUC was 0.988 for only three genes by Q-PCR. 26% of adults and 64% of children with excellent liver allograft function, on minimal or dual immunosuppression, showed high prediction scores for tolerance. Novel peripheral transcriptional profiles can be identified in operational tolerance in pediatric and adult recipients of liver allografts, suggesting a high incidence of a pro-tolerogenic phenotype in stable patients on chronic immunosuppression. Given the high incidence of viral infections and malignancies in liver transplant recipients, this gene set provides an important monitoring tool that can move the field toward personalized and predictive medicine in organ transplantation.


Subject(s)
Biomarkers/blood , Gene Expression Profiling , Liver Transplantation , Transplantation Tolerance/genetics , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic , Young Adult
7.
Pediatr Transplant ; 15(8): 849-54, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22112001

ABSTRACT

As outcomes after ITx improve, greater emphasis is needed on HRQOL. The primary aims of this study were to (i) assess the feasibility of measuring HRQOL in pediatric ITx recipients, (ii) measure HRQOL using validated instruments, and (iii) compare HRQOL in ITx recipients to healthy normal (NL) children. The CHQ and Pediatric Quality of Life (PedsQL4.0) instruments were administered to both patients and parents at outpatient visits. All 24 eligible patients were enrolled. The median age at study enrollment was 6.0 yr (range: 2-18 yr), and the median time from transplant to study enrollment was 2.8 yr (range: 0.5-11.8 yr). The majority of subjects were male (58%), Latino (58%), and liver-inclusive (92%) recipients. For CHQ and PedsQL4.0, parental responses were significantly lower in multiple categories including physical health and social functioning compared to healthy norms. Patient responses were not different from NL using CHQ but using PedsQL4.0 were significantly lower in the school functioning subcategory and psychosocial health summary score. HRQOL as reported by children and families after ITx is significantly lower in multiple categories compared to NL.


Subject(s)
Health Status , Intestines/transplantation , Quality of Life , Adolescent , Child , Child, Preschool , Female , Humans , Male , Parents/psychology , Self-Assessment , Surveys and Questionnaires
8.
Am J Transplant ; 8(12): 2491-5, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18976303

ABSTRACT

Children, especially those under 5 years of age, have the highest death rate on the transplant waiting list compared to any other age range. This article discusses the concept, supported by OPTN data, that there is an age range of small pediatric donors, which are almost exclusively transplanted into small pediatric transplant candidates. Allocation policies that allow broader sharing of small pediatric donors into small pediatric candidates are likely to decrease death rates of children on the waiting list. As well, although the number of pediatric deceased donors continues to decline, improving consent rates for eligible pediatric donors, and judicious use of pediatric donors after cardiac death, can enhance the pediatric deceased donor supply.


Subject(s)
Child Mortality , Organ Transplantation , Transplantation/mortality , Waiting Lists , Adolescent , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Tissue Donors , Tissue and Organ Procurement , United States/epidemiology
9.
Am J Transplant ; 8(4): 739-44, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18318780

ABSTRACT

The publication of the Organ Procurement and Transplantation Network (OPTN) Final Rule in 2000 resulted in a new and different regulatory environment for solid organ transplantation in the United States. In this review the role of the OPTN in providing oversight is clarified, differentiating the powers of enforcement the OPTN and HHS possess compared to the importance of confidential peer review in promoting compliance with OPTN policies. The function of the OPTN's Membership and Professional Standards Committee (MPSC) in adjudicating center performance and investigating alleged violations is described as well as the type and impact of adverse actions that the MPSC can recommend. The role of the OPTN Board compared to that of the Secretary of HHS in determining adverse actions is differentiated. We describe MPSC's broad scope of work in the ongoing evaluation of performance of all transplant centers. Finally, the relationship between the OPTN oversight and other entities charged with safe health care practices in the United States is considered.


Subject(s)
Organ Transplantation/standards , Tissue and Organ Procurement/standards , Delivery of Health Care/standards , Humans , Legislation, Medical , Medicare , Organ Transplantation/legislation & jurisprudence , Organ Transplantation/statistics & numerical data , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/statistics & numerical data , United States
10.
Am J Transplant ; 8(2): 396-403, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18162090

ABSTRACT

Rejection and infection are important adverse events after pediatric liver transplantation, not previously subject to concurrent risk analysis. Of 2291 children (<18 years), rejection occurred at least once in 46%, serious bacterial/fungal or viral infections in 52%. Infection caused more deaths than rejection (5.5% vs. 0.6% of patients, p < 0.001). Early rejection (<6 month) did not contribute to mortality or graft failure. Recurrent/chronic rejection was a risk in graft failure, but led to retransplant in only 1.6% of first grafts. Multivariate predictors of bacterial/fungal infection included recipient age (highest in infants), race, donor organ variants, bilirubin, anhepatic time, cyclosporin (vs. tacrolimus) and era of transplant (before 2002 vs. after 2002); serious viral infection predictors included donor organ variants, rejection, Epstein-Barr Virus (EBV) naivety and era; for rejection, predictors included age (lowest in infants), primary diagnosis, donor-recipient blood type mismatch, the use of cyclosporin (vs. tacrolimus), no induction and era. In pediatric liver transplantation, infection risk far exceeds that of rejection, which causes limited harm to the patient or graft, particularly in infants. Aggressive infection control, attention to modifiable factors such as pretransplant nutrition and donor organ options and rigorous age-specific review of the risk/benefit of choice and intensity of immunosuppressive regimes is warranted.


Subject(s)
Graft Rejection/epidemiology , Infections/epidemiology , Liver Transplantation/immunology , Postoperative Complications/epidemiology , Adolescent , Cause of Death , Child , Graft Rejection/mortality , Humans , Immunosuppressive Agents/therapeutic use , Infections/mortality , Liver Transplantation/adverse effects , Liver Transplantation/mortality , Probability , Recurrence , Reoperation/mortality , Reoperation/statistics & numerical data , Risk Factors , Survival Analysis , Treatment Failure
11.
Transplant Proc ; 39(10): 3387-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18089390

ABSTRACT

BACKGROUND: Poor patient outcomes have been closely linked with perioperative renal function after most solid organ transplants, except intestinal transplantation (ITx). This study examined the effect of peri-ITx renal function on outcome. PATIENTS AND METHODS: A retrospective review of all patients undergoing ITx since 1991 was completed and included 43 patients and 49 transplants. Serum creatinine (sCr) and calculated glomerular filtration rate were compared with peri-ITx and out to 5 years. A renal event (RE) was defined as acute renal failure, immunotherapeutic change driven by poor renal function, or hemodialysis. Comparisons were made based on primary immunotherapeutic regimens-induction interleukin-2 receptor antagonist (IL-2RA; n=31) or standard tacrolimus-based therapy (STD; n=18). Data was analyzed using standard statistical analysis. RESULTS: The frequency of RE was: 60% (STD) versus 31% (IL-2RA) P<.05. RE-associated mortality was 63% (STD) and 27% (IL-2RA) P<.05. Overall mortality was associated with a RE in 50% (STD) and 37% (IL-2RA) of patients. Average sCr across all timepoints was 1.05 (STD) and 0.78 (IL-2RA) P<.003. Surviving patients with RE in STD tended to suffer prolonged renal insufficiency, whereas those in IL-2RA did not. CONCLUSION: This is the first study examining outcomes after ITx related to renal function. Clearly, renal function and RE impacted outcomes. Obtaining RE-free survival and lessening the impact of RE when they do occur is of paramount importance. It appears that IL-2RA immunotherapy reduces RE and their associated morbidity.


Subject(s)
Intestines/transplantation , Glomerular Filtration Rate , Humans , Postoperative Complications/epidemiology , Retrospective Studies , Treatment Outcome
12.
Am J Transplant ; 7(4): 955-63, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17391135

ABSTRACT

Posttransplant de novo autoimmune hepatitis (d-AIH) is increasingly described as a long-term complication after pediatric liver transplantation (LT). d-AIH is characterized by graft dysfunction, the development of autoimmune antibodies and histologic evidence of hepatitis in liver transplant recipients without previous history of autoimmune liver disease. This study is a matched case-control, univariate analysis aimed at identifying risk factors for the development of d-AIH and evaluating response to treatment. From 1984 to 2003, 619 children received 788 LTs at a single center. Forty-one patients developed d-AIH and were matched with controls for year of LT, age at time of LT and diagnosis. The following variables were insignificant in the development of d-AIH: age, gender, race, initial diagnosis, ischemia time, graft type, Epstein-Barr virus and cytomegalovirus status, HLA typing and primary immunosuppression. Compared to controls, d-AIH patients were less likely to be on monotherapy immunosuppression or weaned off prednisone at the time of diagnosis. The d-AIH group relative to the controls had statistically significant greater numbers of rejection episodes. d-AIH was treated with prednisone and/or MMF in 39 of 41 patients and lead to significant improvements in liver function tests. Thirty-nine patients are alive at a mean of 4.0 years follow-up after diagnosis. Three have required retransplantation.


Subject(s)
Graft Rejection/pathology , Hepatitis, Autoimmune/epidemiology , Liver Transplantation/adverse effects , Postoperative Complications/epidemiology , Adolescent , Biopsy , Child , Drug Therapy, Combination , Graft Rejection/epidemiology , Hepatitis, Autoimmune/pathology , Histocompatibility Testing , Humans , Immunosuppressive Agents/therapeutic use , Liver Transplantation/immunology , Retrospective Studies , Risk Factors
13.
Transplant Proc ; 38(6): 1718-9, 2006.
Article in English | MEDLINE | ID: mdl-16908260

ABSTRACT

BACKGROUND: This study sought to describe the long-term nutritional outcomes of children after intestinal transplant (SBT). METHODS: Between 1991 and March 2005, 30 children received 33 SBT at a single center. Eligibility criteria included patient and graft survival >6 months. Weight, height, albumin, prealbumin, zinc (Zn), and essential fatty acid (EFA) levels were reviewed retrospectively. RESULTS: The 19 patients who met inclusion criteria had a median age at SBT of 2.9 years. The majority of patients were male, Latino, transplanted for necrotizing enterocolitis and received combined liver-SBT. All patients were weaned off total parenteral nutrition to elemental formula at a mean of 39 days post-SBT. Seventeen of 19 patients were Zn deficient and four patients were EFA deficient post-SBT. CONCLUSIONS: Pre-SBT most subjects were significantly deficient in anthropometric and biochemical parameters. Post-SBT the mean Z score for weight and height improved significantly at year 1, then leveled off in year 2. Serum protein levels improved from pre-SBT, yet remained low-normal. Zn deficiency was seen frequently after SBT and is under investigation. Children who developed EFA deficiency were on the same formula, receiving inadequate EFA supplementation. Successful SBT was associated with growth and maintenance of serum nutritional parameters but not with significant catch-up growth.


Subject(s)
Intestine, Small/transplantation , Nutritional Physiological Phenomena , Transplantation, Homologous/physiology , Adolescent , Child , Child, Preschool , Cohort Studies , Fatty Acids, Essential/blood , Follow-Up Studies , Graft Survival , Humans , Patient Selection , Retrospective Studies , Treatment Outcome
14.
Pediatr Transplant ; 8(3): 284-94, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15176967

ABSTRACT

Studies of Pediatric Liver Transplantation (SPLIT) was initiated in 1995 for the purpose of collecting comprehensive data from children undergoing liver transplantation. As of May 31, 2002, 1761 children were registered in SPLIT from 38 participating centers in the United States and Canada. This report focuses on the demographics, primary diagnoses, clinical indications for transplant, and probability of obtaining liver transplantation for the 1187 children receiving a liver transplant after registration in SPLIT. Demographic information is also provided for the 1092 children who received their first ever liver transplantation. For this cohort, we also describe immunosuppressive practices at the time of transplant, and how the use of different medications changes with time.


Subject(s)
Immunosuppressive Agents/therapeutic use , Liver Transplantation/statistics & numerical data , ABO Blood-Group System , Adolescent , Canada , Child , Child, Preschool , Drug Utilization , Female , Humans , Infant , Liver Diseases/surgery , Male , Registries , Time Factors , Tissue Donors , United States
15.
Transplant Proc ; 36(2): 263-4, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15050128

ABSTRACT

AIM: To analyze the role of P-selectin in intestinal ischemia and reperfusion injury (IRI) using murine models. METHODS: A model of warm IRI wherein the SMA was occluded for 100 minutes was undertaken in the following groups (10 mice per group): Group 1 (control) wild-type (WT) C57BL6, no treatment; Group 2: 0.4 mg/kg of r-PSGL1-lg 10 minutes before and after clamping; Group 3: PSGL KO mice. Survival was assessed at 7 days; the intestine was assayed for histopathology, apoptosis, myeloperoxidase (MPO), IL1, and TNF. A second model of cold IRI followed by intestinal transplantation (IT) was undertaken in the following groups (two mice per group): Group A WT --> WT: Group B PSGL KO --> WT (1-hour ischemia); Group C: PSGL KO --> WT (2 hour ischemia). Survival only was assessed. RESULTS: Survival was 50% in group 1, 90% in group 2, and 100% in group 3. Graded histopathology and crypt apoptosis demonstrated significantly less injury in groups B and C. MPO was not different between groups. IL1 and TNF were significantly reduce in groups 2 and 3. Following IT, survival was <12 hours in group A, >7 days in group B, and <72 hours in group C. CONCLUSION: This study clearly demonstrates the importance of P-selectin in warm and cold IRI in that the blockade of P-selectin using rPSGL1-lg or the absence of P-selectin using KO mice confers a survival advantage and reduction in tissue injury. The mechanism is unclear but appears to be independent of neutrophil infiltration.


Subject(s)
Intestine, Small/transplantation , P-Selectin/physiology , Animals , Intestine, Small/blood supply , Intestine, Small/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , P-Selectin/genetics , Reperfusion Injury , Survival Analysis , Transplantation, Homologous/pathology , Treatment Outcome
16.
Transplant Proc ; 36(2): 303-4, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15050139

ABSTRACT

PURPOSE: To evaluate the outcomes of patients undergoing intestinal transplantation (IT). METHODS: Retrospective review was undertaken using existing medical records and database. RESULTS: Between November 1991 and May 2003, 114 patients were referred for consideration for IT, of which 33 patients received 37 intestinal allografts. All patients had intestinal failure and all patients had significant complications from total parenteral nutrition (TPN). TPN was the predominant cause of liver failure (63%). Combined liver intestinal grafts were used in the majority of patients. Overall 1- and 3-year patient survival is 77% and 52% with patients transplanted since 1999 having a 1- and 3-year survival of 94% and 73%, respectively. The most common cause of death was sepsis. No graft or patient was lost to cytomegalovirus or Epstein-Barr virus disease. Twenty-seven percent of allografts were lost to rejection. Long-term TPN independence is 82% for grafts more than 30 days after IT. Statistical analysis revealed several important factors impacting outcome. CONCLUSIONS: Successful IT defined as prolonged patient and graft survival and TPN independence can be readily achieved in select patients with IF and complications related to TPN therapy. Outcomes have improved with experience gained and control of viral infections and rejection.


Subject(s)
Intestines/transplantation , Adolescent , Adult , Child , Child, Preschool , Female , Follow-Up Studies , Graft Rejection/epidemiology , Graft Survival/physiology , Humans , Infant , Male , Middle Aged , Parenteral Nutrition, Total/adverse effects , Retrospective Studies , Survival Analysis , Time Factors , Transplantation, Homologous/methods , Transplantation, Homologous/mortality , Transplantation, Homologous/physiology , Treatment Outcome
17.
Transplant Proc ; 36(2): 314-5, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15050143

ABSTRACT

Liver-intestinal transplantation is a complex surgical procedure that historically has required prolonged operative periods. This report is the first series where liver-intestinal transplantation was performed as a staged procedure. Specifically, allograft reperfusion was followed by resuscitation and stabilization in an intensive care unit before completion of the transplant procedure. Triage of recipients to the intensive care unit following allograft reperfusion was determined at the time of operation and was based upon the clinical condition of the recipient including hemodynamic stability, evidence of coagulopathy, and assessment of early liver function. Medical stabilization was followed by completion of the transplant procedure and definitive abdominal closure within 72 hours. The application of combined liver-intestinal transplantation as a staged procedure demonstrated no effect upon early graft function, incidence of complications, or ability to perform a definitive abdominal closure.


Subject(s)
Intestines/transplantation , Liver Transplantation/methods , Transplantation, Homologous/methods , Adult , Child , Hemodynamics , Humans , Monitoring, Intraoperative , Retrospective Studies
18.
Transplant Proc ; 36(2): 331-2, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15050149

ABSTRACT

PURPOSE: To determine the effectiveness of induction immunotherapy with interleukin-2 receptor antagonists (IL2RA) after intestinal transplantation (IT). METHODS: A single-center, retrospective study was undertaken of all patients undergoing IT using existing medical records and database. Immunotherapy was either triple (standard maintenance triple therapy [SMTT]) or IL2RA [induction IL2RA plus SMTTx] or OKT3 [induction antilymphocyte preparations plus SMTTx]). Data was collected for the first 175 postoperative days. Outcomes included pretransplant renal function, posttransplant serum creatinine normalized to age (nl-sCR), rejection (ACR), and survival. Standard statistical analysis was undertaken. RESULTS: There were no significant differences in the groups: triple (n = 10, median age 3.5 years, cGFR 106 +/- 44 mL/min), IL2RA (n = 13, median age 3.2 years, cGFR 101 +/- 61 mL/min), OKT3 (n = 4, median age 7.7 years, cGFR 104 +/- 27 mL/min). nl-sCR was significantly (P <.01) lower in IL2RA at most postoperative weeks. IL2RA had significantly fewer rejection and infectious episodes than the other two groups. Three-year patient survival was 92% in IL2RA versus 50% triple and OKT3. CONCLUSIONS: IL2RA immunotherapy after IT is associated with a lower incidence of renal dysfunction as compared with historical controls. Furthermore, IL2RA therapy resulted in a lower incidence of rejection and improved survival. IL2RA should be considered in select patients undergoing IT.


Subject(s)
Glomerular Filtration Rate/physiology , Immunosuppressive Agents/therapeutic use , Receptors, Interleukin-2/antagonists & inhibitors , Child , Child, Preschool , Graft Rejection/epidemiology , Graft Rejection/prevention & control , Humans , Muromonab-CD3/therapeutic use , Retrospective Studies
19.
Transplant Proc ; 36(2): 379-80, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15050165

ABSTRACT

AIM: To review the incidence, timing, and outcome of infectious enteritis after intestinal transplantation (IT). METHOD: A retrospective review of all patients undergoing IT at a single institution between 1991 and 2003 was analyze with standard statistical tools. RESULTS: Among 33 IT recipients, 13 (39%) developed 20 culture- or biopsy-proven episodes of infectious enteritis. The recipient demographics were 77% men and median age 2.6 years. Infections were diagnosed at a median of 76 days (32 to 1800) after IT. There were 14 viral (CMV one, rotavirus eight, adenovirus four, EBV one, three bacterial (Clostridium difficile), and three other infections (Giardia lamblia one, cryptosporidium two). Complete resolution was achieved in 17 (94%) infectious after appropriate antimicrobial or conservative therapy. Interestingly, there were six rejection episodes following infectious enteritis. Grafts were lost to rejection after rotaviral enteritis (n = 1) and adenoviral enteritis misdiagnosed as rejection (n = 1). Patient and graft survival were not adversely affected by infections. CONCLUSIONS: Infectious enteritis occurs frequently after IT. Viral agents are the cause in two-thirds of cases. With supportive care and appropriate treatment, resolution is possible in the majority of cases. Differentiating rejection and infection by histopathology can be difficult.


Subject(s)
Bacterial Infections/epidemiology , Enteritis/epidemiology , Intestines/transplantation , Virus Diseases/epidemiology , Adult , Child , Female , Humans , Intestines/microbiology , Male , Postoperative Complications/microbiology , Postoperative Complications/virology , Retrospective Studies , Time Factors , Treatment Outcome
20.
Clin Transpl ; : 119-30, 2003.
Article in English | MEDLINE | ID: mdl-15387103

ABSTRACT

The SPLIT database is accumulating comprehensive data on both pre- and posttransplant outcomes after pediatric liver transplantation. The relatively small numbers of children receiving any solid organ transplant, even at the largest single centers makes it difficult to study outcomes and changing trends from any single center and necessitates the formation of a large multi-center database. SPLIT has designed its data collection specifically to address outcomes relevant to children after liver transplantation such as growth and school performance and which are not collected by any other exisiting database. From the outcome data generated to date, a subset of which is presented above, hypothesis-driven studies can be designed. The first example of such a study was the development of the Pediatric Endstage Liver Disease (PELD) score. This model, which predicts death on the liver transplant waiting list for children with chronic liver disease was developed using data from SPLIT, has been adopted, and subsequently verified within the national cadaveric organ allocation system.


Subject(s)
Liver Transplantation , Pediatrics , Adolescent , Adult , Child , Child, Preschool , Demography , Female , Graft Rejection/epidemiology , Hospitalization , Humans , Incidence , Infant , Liver Diseases/surgery , Liver Failure/mortality , Liver Transplantation/adverse effects , Male , Pediatrics/methods , Postoperative Period , Time Factors , Tissue Donors , United States , Waiting Lists
SELECTION OF CITATIONS
SEARCH DETAIL
...